Search Results - "Leichtle, A.B."

A Bayesian spatiotemporal model for prevalence estimation of a VRE outbreak in a tertiary care hospital by Atkinson, A., Ellenberger, B., Piezzi, V., Kaspar, T., Endrich, O., Leichtle, A.B., Zwahlen, M., Marschall, J.

“…There was a nosocomial outbreak of vancomycin-resistant enterococci (VRE) at the hospital between 1st January 2018 and 31st July 2020. The goals of this study…”
Get full text

Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers by Pradervand, S., Freundler, N., Gosztonyi, B., Roncoroni, L., Achermann, R., Schwenk, T., de Fraipont, G., Garessus, J., Haefliger, S., Leichtle, A.B., Kiessling, M.K., Mueller-Focke, T., Krebs, F.S., Zoete, V., Tsantoulis, P., Michielin, O., Britschgi, C., Wicki, A.

Get full text

Doubling immunochemistry laboratory testing efficiency with the cobas e 801 module while maintaining consistency in analytical performance by Findeisen, P., Zahn, I., Fiedler, G.M., Leichtle, A.B., Wang, S., Soria, G., Johnson, P., Henzell, J., Hegel, J.K., Bendavid, C., Collet, N., McGovern, M., Klopprogge, K.

“…The new immunochemistry cobas e 801 module (Roche Diagnostics) was developed to meet increasing demands on routine laboratories to further improve testing…”
Get full text